Abvc Biopharma (ABVC) Receivables - Other (2018 - 2025)
Abvc Biopharma (ABVC) has disclosed Receivables - Other for 9 consecutive years, with $2347.0 as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Receivables - Other fell 99.6% year-over-year to $2347.0, compared with a TTM value of $2347.0 through Dec 2025, down 99.6%, and an annual FY2025 reading of $2347.0, up 24.05% over the prior year.
- Receivables - Other was $2347.0 for Q4 2025 at Abvc Biopharma, down from $1.9 million in the prior quarter.
- Across five years, Receivables - Other topped out at $1.9 million in Q3 2025 and bottomed at $1867.0 in Q1 2025.
- Average Receivables - Other over 5 years is $394430.4, with a median of $145399.0 recorded in 2021.
- The sharpest move saw Receivables - Other crashed 99.69% in 2024, then surged 98762.64% in 2025.
- Year by year, Receivables - Other stood at $145399.0 in 2021, then surged by 253.39% to $513819.0 in 2022, then skyrocketed by 45.49% to $747573.0 in 2023, then decreased by 21.17% to $589340.0 in 2024, then plummeted by 99.6% to $2347.0 in 2025.
- Business Quant data shows Receivables - Other for ABVC at $2347.0 in Q4 2025, $1.9 million in Q3 2025, and $1.4 million in Q2 2025.